
What We Know About Long Covid
Interactive Video
•
Business, Health Sciences, Biology
•
University
•
Practice Problem
•
Hard
Wayground Content
FREE Resource
The transcript discusses the speaker's personal experience with Lyme disease and its long-term effects, drawing parallels to the emerging chronic condition of long COVID. It highlights the symptoms and challenges faced by long COVID patients, known as long haulers, and the efforts of Bio Incept, a biotech company focused on treating autoimmune diseases and promoting tissue regeneration. The speaker, who transitioned from a banking career to biotech, outlines Bio Incept's plans for a public listing and a study on long COVID, emphasizing the potential impact on patients and the healthcare system.
Read more
3 questions
Show all answers
1.
OPEN ENDED QUESTION
3 mins • 1 pt
What is the focus of Bio Incept as mentioned in the text?
Evaluate responses using AI:
OFF
2.
OPEN ENDED QUESTION
3 mins • 1 pt
What unique opportunity did the speaker see in transitioning to Bio Incept?
Evaluate responses using AI:
OFF
3.
OPEN ENDED QUESTION
3 mins • 1 pt
What potential does the speaker see for Bio Incept in the near future?
Evaluate responses using AI:
OFF
Access all questions and much more by creating a free account
Create resources
Host any resource
Get auto-graded reports

Continue with Google

Continue with Email

Continue with Classlink

Continue with Clever
or continue with

Microsoft
%20(1).png)
Apple
Others
Already have an account?